A Multicenter, Open-Label, Extension Study to Assess the Long-Term Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
A Multicenter, Open-Label, Extension Study to Assess the Long-Term Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, severe alopecia areata. Patients from European sites who previously completed a qualifying CTP-543 clinical trial may participate in this study.
Inclusion Criteria:
Exclusion Criteria:
Nice, Provence-Alpes-Côte d'Azur Region 06202, France
Münster, North Rhine-Westphalia 48149, Germany
Berlin, 10117, Germany
Pécs, Baranya 7632, Hungary
Szeged, Csongrad-Csanad County 6720, Hungary
Budapest, Pest County 1085, Hungary
Skierniewice, Masovian Voivodeship 96-100, Poland